Stoneridge Investment Partners LLC Amgen Inc Transaction History

Stoneridge Investment Partners LLC

  • $263 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022
SELL
$219.27 - $242.57 $1.28 Million - $1.42 Million
-5,838 Closed
0 $0
Q4 2021

Feb 02, 2022
SELL
$198.88 - $227.6 $701,052 - $802,290
-3,525 Reduced 37.65%
5,838 $1.31 Million
Q3 2021

Nov 03, 2021
BUY
$212.27 - $248.7 $1.99 Million - $2.33 Million
9,363 New
9,363 $1.99 Million

Others Institutions Holding AMGN

# of Institutions
2,932
Shares Held
401M
Call Options Held
6.59M
Put Options Held
6.6M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Stoneridge Investment Partners LLC Portfolio

Follow Stoneridge Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stoneridge Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stoneridge Investment Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email